Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer
Running, not enrolling · Not applicable
Conditions studied: Prostate Carcinoma
In brief
This phase II trial studies how well multiparametric magnetic resonance imaging (MRI) works in evaluating cancer stage and helping treatment planning in patients with prostate cancer. Multiparametric MRI may be useful for evaluating the type of cancer in finding aggressive disease.
Key facts
- Study ID
- NCT03697148
- Run by
- ECOG-ACRIN Cancer Research Group
- People needed
- 852
- Starts
- 2019-02-11
- Expected to finish
- 2026-12-31
- Last updated by the study team
- 2026-07-17
Who can join
Age: 18 and older. Sex: male. Healthy volunteers: not accepted.
You may qualify if…
- Recently diagnosed with prostate cancer for whom definitive surgical treatment is indicated
You may not qualify if…
- Not suitable to undergo MRI or receive gadolinium-based contrast agent (severe, untreatable claustrophobia; MRI-incompatible metallic objects or implanted medical devices; renal failure; weight greater than allowable by scanner per institutional standard practice)
- Prior surgical and/or non-surgical treatment for prostate cancer
- Prior hip replacement or other major pelvic surgery
Where it is running
- Mayo Clinic Hospital in Arizona — Phoenix, Arizona, United States
- Mayo Clinic in Arizona — Scottsdale, Arizona, United States
- Yale University — New Haven, Connecticut, United States
- University of Florida Health Science Center - Jacksonville — Jacksonville, Florida, United States
- Mayo Clinic in Florida — Jacksonville, Florida, United States
- Queen's Medical Center — Honolulu, Hawaii, United States
- Straub Clinic and Hospital — Honolulu, Hawaii, United States
- Pali Momi Medical Center — ‘Aiea, Hawaii, United States
- Straub Pearlridge Clinic — ‘Aiea, Hawaii, United States
- Midwestern Regional Medical Center — Zion, Illinois, United States
- Indiana University/Melvin and Bren Simon Cancer Center — Indianapolis, Indiana, United States
- University of Iowa/Holden Comprehensive Cancer Center — Iowa City, Iowa, United States
- University of Kansas Cancer Center — Kansas City, Kansas, United States
- University of Kansas Hospital-Indian Creek Campus — Overland Park, Kansas, United States
- East Jefferson General Hospital — Metairie, Louisiana, United States
- LSU Healthcare Network / Metairie Multi-Specialty Clinic — Metairie, Louisiana, United States
- Brigham and Women's Hospital — Boston, Massachusetts, United States
- Henry Ford Hospital — Detroit, Michigan, United States
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital — Grand Rapids, Michigan, United States
- Henry Ford West Bloomfield Hospital — West Bloomfield, Michigan, United States
- Mayo Clinic in Rochester — Rochester, Minnesota, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Mercy Hospital Saint Louis — St Louis, Missouri, United States
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center — Lebanon, New Hampshire, United States
- NYP/Weill Cornell Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.